|
Over the years, Genotypic has able to establish a rapport with a number of research institutions/ companies most of whom have been long standing clients. Genotypic's advanced and high value services are trusted and utilized by academia, research & development and pharma-biotech companies across the globe including those from USA, Canada, Australia, France, Israel, Singapore and India.
Customers
Indian academic research institutes – NCBS (Bangalore), Alagappa University (TamilNadu), Christian Medical College (Vellore) , Institute of Bioinformatics (Bangalore) , BMHRC (Bhopal) , Thrombosis Research Institute (Bangalore) , ICGEB (Delhi) , DRDE (Gwalior) , DIPAS (Delhi) , ACTREC (Mumbai) , AIIMS (Delhi) , JNU (Delhi) , IISc – (Dept. of MCBL) , IISc – (Dept. of Biochemistry) , IISc – (Dept. of MRDG) , JNCASR (Bangalore) , JALMA (Agra) , TRC (Chennai) , IOP (Delhi) , NIRRH (Mumbai) , IIH (Mumbai) , MCC (Pune) , NIV (Pune) , IVRI (Izatnagar) , NBAGR, (Karnal) , CCMB (Hyderabad) , CDRI (Lucknow) , IMTECH (Chandigarh) , ITRC (Lucknow) , CDFD (Hyderabad) , NII (Delhi) , NCPGR (Delhi) , NBRC (Gurgaon) , NCCS (Pune) and other Institutes under ICMR, ICAR, DBT and CSIR.
Indian Pharma / Biotech customers - Dr. Agarwal Hospitals, Bangalore , Unilever, Bangalore , AstraZeneca, Bangalore , Lupin, Pune ,Advanced Enzyme Technologies, Pune , ITC, Hyderabad , KEMIN, Chennai , Dr. Reddys Laboratories, Hyderabad.
Overseas – National University of Singapore, La Trobe University Research Biolabs, Hellenic Pasteur
Institute, EMBL, Weizmann Institute, Eldan scientific associates, Quark Biotech, Evogene, Duke Medical
Center, New York Hospital, CDC, Methylgene, Aveopharma, Agilent Technologies.
Testimonials
Genotypic offers quick service, swift analysis and crisp interpretation. Their technical expertise in different areas of microarray technology has been of great value to us.
Microarray team of Astra Zeneca (India)
"We worked with genotypic for gene expression profiling of three of our enzyme healthcare formulations. From the results provided by Genotypic we could quickly understand the mechanism of action of the formulations. The results were of high standard and acceptable to the medical community. The Microarray studies for the fourth and fifth formulations are currently underway.
Shilpa S.,
Manager, Product development, Advanced Enzyme Technologies Ltd., (Speciality enzymes and Biochemicals, Inc).
We are using Genotypic's microarray services for the past 3 years. It is Great!
Prof. Arunkumar ,
MRDG, Indian Institute of Science, Bangalore.
Our initial experience with Genotypic Technology for our gene expression analysis using microarrays was positive. We were pleased with the level of professionalism and the diligence with which Genotypic Technology carried the analysis. Their experts are very knowledgeable to give us generous consults on study design and are very cooperative with our requests. The final reports were generated with user-friendly format and were delivered on time. We will plan to use Genotypic Technology in the future for more microarray studies.
Dr.Zuomei Li,
Methylgene Inc., Canada
Biointerpreter allowed me to see clear functional difference of 3 categories of ovarian tumors. I got a better view of the Biology behind the differential expression.
James Cherry, SAIC-Frederick,
NCI at Frederick. Gene Expression Laboratory, MD, USA
These are not ME TOO tools; these address the unmet need of biological interpretation of Microarray data.
Preveen Ramamoorthy ,
Medimmune vaccines Inc, CA USA.
The software is very useful in microarray data interpretation and in predicting mechanism of action.
Dr. Abhijit Chatterjee,
Zydus Research Centre, India
Genotypic has developed an essential tool for analysis of microarray data. This tool helps even a beginner to achieve better interpretation of microarray data. I hope Genotypic will continue to develop such tools to assist the microarray-gene expression community.
Dr.Sanjeev Galande,
National Centre for Cell Science, India
I have been using your BioInterpreter tool a lot recently. It is absolutely fabulous! A real gold mine for microarray analysis!
Claire Bonfils,
Senior Research Scientist, Methylgene Inc, Canada
|
|
|
